George

[George @george_deng7]

$TENX Primary Completion
2026-06-30 [Actual]

https://t.co/P2MQxXg9uB

[George @george_deng7]

$SLS 2-17-2020: Enrollment 116 [Estimated]
1-27-2023: Enrollment 140
3-26-2024: Enrollment 126 [Actual]
10 patients more than original estimated 116 to 126, cut short from increased estimate 140, but kept events to 80 from 105, this is as a BULLISH sign as it can be, IMO.

[George @george_deng7]

$SLS What is IDMC going to do if the remaining 48 patients in REGAL are in CR or "cured" and may live many more months to years?

[George @george_deng7]

@charle77238 $SLS The primary endpoint is HARD gold standard OS on 80 events, NO one can fake death.

[George @george_deng7]

$SLS The whole $1-$10 option chain has about 50M shares open interests, plus 57M short interest....

[George @george_deng7]

$SLS Today's presentation is telegraphing REGAL success, any day now, a violent short squeeze may happen because all 57M short positions, and about 30+M shares of 2027 and 2028 calls in the money, sellers of those positions are under water now, IMO.

[George @george_deng7]

$SLS AI: stock call option sellers typically need to increase their hedge ratio—meaning they buy more of the underlying stock—as call options go in-the-money and the stock price rises, known as delta hedging, rebalances to maintain a neutral position against rising upward risk.

[George @george_deng7]

$SLS To add more fire: there are about 110k Jan 2028 call open interests too, about 90K $6 or lower are in the money now, for Jan 2027 calls, about 233K are in the money today.

[George @george_deng7]

$SLS Some funds bought huge Jan 2027 calls, there are about 260K Jan 2027 call open interests and about 20k calls traded today, only about 5k put open interests, these are overwhelming bullish bets by BIG GUYS, IMO.

[George @george_deng7]

$SNDK Action: The company raised NAND flash prices by over 10% starting April 1, 2026.
Industry Context: Market researchers anticipated NAND flash contract prices to increase between 70% and 75% in the second quarter of 2026 compared to Q1.
From GOOGLE AI reply about SNDK.

[George @george_deng7]

@JamieMcullough It is a national security issue now to keep AI bubble going as long as possible, if it bursts, the economy may go with it, so it is not allowed by all means, IMO.

[George @george_deng7]

$SNDK It is reasonable to expect SNDK to report huge Q1 estimate beat and guides 2026 big upside, possible bonus of 5 to 1 stock split and stock buyback program with about 2026 estimate $6.5B net profits on April 30, IMO.

[George @george_deng7]

$SNDK Correction: Calendar year 2026 year net profits may be close $12B....SNDK may choose to reward shareholders by buying back stocks, IMO.

[George @george_deng7]

@BillyBobBleach @ZShen3427 $GOSS High risk is like OCUL, hit the primary endpoint P <0.05 or better that leave street to figure out what is the potential market shares, what GOSS needs is very strong efficacy data that leave no question of $1-2B billion revenue potential, IMO.

[George @george_deng7]

$GOSS More, the OLE closed recruiting on 2026-1-6
with 316 patients enrolled, 81% of 390 patients enrolled in PROSERA, good number patients, IMO. I am betting on very strong efficacy side.

[George @george_deng7]

@ZShen3427 If the p3 fails completely, the $200M 2027 convertible holders may force GOSS into bankruptcy, IMO.

[George @george_deng7]

@ZShen3427 $GOSS Too late for P2 patients, P2 completed on 2022-11-01 and P3 OLE started on 2024-09-03, IMO.

[George @george_deng7]

@ZShen3427 $GOSS So many bullish actions from GOSS, including P3 PH-ILD recruiting started on 11-07-2025...

[George @george_deng7]

@ZShen3427 $GOSS Management comments: Very excited from PAH community Vs cold reactions from investment community.

[George @george_deng7]

@ZShen3427 $GOSS Yes, I do not know how can street miss this critical information on https://t.co/dQ4ECccePl that PROSERA
Study Completion (Actual) 2025-12-22 and PROSERA-EXT Active, not recruiting on Jan 6, 2026.